Your browser doesn't support javascript.
loading
Successful rechallenge of alectinib after remission of severe alectinib-induced interstitial lung disease.
Huang, Jhong-Ru; Chou, Chung-Wei; Chao, Heng-Sheng.
Affiliation
  • Huang JR; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei.
  • Chou CW; General Chest Medicine, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei.
  • Chao HS; General Chest Medicine, Department of Chest Medicine, Taipei Veterans General Hospital, Taipei.
J Oncol Pharm Pract ; 27(5): 1311-1314, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33054691
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Carbazoles / Lung Diseases, Interstitial / Adenocarcinoma of Lung / Lung Neoplasms Limits: Aged / Female / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Carbazoles / Lung Diseases, Interstitial / Adenocarcinoma of Lung / Lung Neoplasms Limits: Aged / Female / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2021 Document type: Article Country of publication: